Michelle A Baron

2PUBLICATIONS
2CO-AUTHORS
Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Jan 06, 2018
Clinical Impact of ITCA 650, a Novel Drug-Device GLP-1 Receptor Agonist, in Uncontrolled Type 2 Diabetes and Very High Baseline HbA1c: The FREEDOM-1 HBL (High Baseline) Study.

Robert R Henry, Julio Rosenstock, Douglas S Denham

|Dec 16, 2017
Efficacy and Safety of ITCA 650, a Novel Drug-Device GLP-1 Receptor Agonist, in Type 2 Diabetes Uncontrolled With Oral Antidiabetes Drugs: The FREEDOM-1 Trial.

Julio Rosenstock, John B Buse, Rehan Azeem

Pageof 1

Frequent Collaborators

2 joint publications

Julio Rosenstock

1 joint publications

Robert R Henry